Search alternatives:
significantly enriched » significantly enhanced (Expand Search), significantly increased (Expand Search), significantly decreased (Expand Search)
lower decrease » linear decrease (Expand Search), larger decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 1 - 20 results of 29,099 for search '(( significantly enriched increased ) OR ( significantly ((lower decrease) OR (teer decrease)) ))', query time: 0.42s Refine Results
  1. 1
    Significantly decreased necrosis observed on wheat leaves inoculated with <i>ΔZtknr4</i>.

    Significantly decreased necrosis observed on wheat leaves inoculated with <i>ΔZtknr4</i>. by Erika Kroll (20537020)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Full list of proteins significantly enriched by BioID2 labelling.

    Full list of proteins significantly enriched by BioID2 labelling. by Jan Pyrih (229124)

    Published 2020
    Save to List
    Saved in:
  3. 3
    Significantly Enriched Pathways.

    Significantly Enriched Pathways. by Jiyong Zhang (2498740)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Significantly enriched pathways.

    Significantly enriched pathways. by Lufei Hu (3187827)

    Published 2022
    Save to List
    Saved in:
  5. 5
    KEGG enrichment map of differential metabolites (a) and differential abundance score map (b).

    KEGG enrichment map of differential metabolites (a) and differential abundance score map (b). by Jun Sun (48981)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease.

    N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. by Noelia Carballeda-Sangiao (2889611)

    Published 2020
    Save to List
    Saved in:
  7. 7
    The receiver operating characteristic curve (ROC) for using ucfDNA molecules with a size range of 130 to 160 bp within the DHSs to distinguish control subjects with hematuria from bladder cancer subjects.

    The receiver operating characteristic curve (ROC) for using ucfDNA molecules with a size range of 130 to 160 bp within the DHSs to distinguish control subjects with hematuria from... by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 8
    Heatmap showing the end motifs of ucfDNA among different groups.

    Heatmap showing the end motifs of ucfDNA among different groups. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 9
    Analysis of ucfDNA in DHSs between control and age-comparable bladder cancer groups.

    Analysis of ucfDNA in DHSs between control and age-comparable bladder cancer groups. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 10
    ROC analysis for differentiating bladder cancer patients from controls using the ucfDNA concentration before and after normalization by creatinine concentration in those samples with the availability of creatinine measurements (38 controls versus 21 bladder cancer patients).

    ROC analysis for differentiating bladder cancer patients from controls using the ucfDNA concentration before and after normalization by creatinine concentration in those samples wi... by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 11
    Size distributions of ucfDNA molecules.

    Size distributions of ucfDNA molecules. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 12
    Relationship of motif rankings in ucfDNA between WT and nuclease deficient mice.

    Relationship of motif rankings in ucfDNA between WT and nuclease deficient mice. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 13
    DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup><i>-/-</i></sup> mice with quantifiable ucfDNA using Qubit assay.

    DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup><i>-/-</i></sup> mice with quantifiable ucfDNA using Qubit assay. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 14
    Overview of the study design.

    Overview of the study design. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 15
    The end density of ucfDNA across different tissue types.

    The end density of ucfDNA across different tissue types. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 16
    End density of the ucfDNA fragments within the DHSs.

    End density of the ucfDNA fragments within the DHSs. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 17
    Percentages of ucfDNA fragments starting with T.

    Percentages of ucfDNA fragments starting with T. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 18
    Comparison of <i>DNASE1</i> mRNA expression levels in bladder tumoral tissues (n = 41) and adjacent non-tumoral tissues (n = 19) using the TCGA dataset.

    Comparison of <i>DNASE1</i> mRNA expression levels in bladder tumoral tissues (n = 41) and adjacent non-tumoral tissues (n = 19) using the TCGA dataset. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 19
    S8 Fig -

    S8 Fig - by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 20
    DNA concentrations of ucfDNA in WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup>-/-</sup> mice.

    DNA concentrations of ucfDNA in WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup>-/-</sup> mice. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: